Sort   by:  
 Page size 
UnknownPhase 2 study of pembrolizumab in patients with advanced rare cancers.
Not available
S-EPMC7078933 | biostudies-literature
GenomicsGenomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis.
Oesophageal adenocarcinoma (EAC) incidence is rapidly increasing in Western countries. A better understanding of EAC underpins efforts to improve early detection and treatment outcomes. While large EAC exome sequencing efforts to date have found recurrent loss-of-function mutations, oncogenic drivin...
EGAS00001000750 | EGA
GenomicsWTCCC2 Visceral Leishmaniasis (VL) samples
A WTCCC2 project genome-wide association study for visceral leishmaniasis (VL) in individuals from India, Brazil and Sudan, genotyped on the custom Illumina 670k array. The WTCCC2 analysis of the Brazilian and Indian samples is described in Fakiola et al. [Nat Genet. 2013 Feb;45(2):208-13]. It shoul...
EGAS00001000773 | EGA
GenomicsQCMG_20140410_OESO - samples
Description not provided
EGAD00001000845 | EGA
GenomicsWhole Genome Sequencing of Esophageal Adenocarcinomas DAC
Data Access Committee EGAC00001000192
EGAC00001000192 | EGA
UnknownEarly Convalescent Plasma for High-Risk Outpatients with Covid-19.
Not available
S-EPMC8385553 | biostudies-literature
UnknownEvaluating Pediatric Sepsis Definitions Designed for Electronic Health Record Extraction and Multicenter Quality Improvement.
Not available
S-EPMC7677030 | biostudies-literature
GenomicsWTCCC2 VL Brazil - samples
WTCCC2 Visceral Leishmaniasis samples from Brazil using Illumina 670k
EGAD00010000636 | EGA
GenomicsWTCCC2 VL Sduan - samples
WTCCC2 Visceral Leishmaniasis samples from Sudanl using Illumina 670k
EGAD00010000640 | EGA
GenomicsWTCCC2 VL India - samples
WTCCC2 Visceral Leishmaniasis samples from Indial using Illumina 670k
EGAD00010000638 | EGA
Sort   by:  
 Page size